We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$10.9B
AUM Growth
+$1.02B
Cap. Flow
+$744M
Cap. Flow %
6.82%
Top 10 Hldgs %
30.62%
Holding
3,895
New
1,275
Increased
565
Reduced
595
Closed
1,134

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Healthcare 9.21%
3 Consumer Discretionary 8.28%
4 Industrials 6.28%
5 Materials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLJ icon
2001
RLJ Lodging Trust
RLJ
$1.83B
$376K ﹤0.01%
24,694
-18,252
-42% -$285K
RPTX
2002
DELISTED
Repare Therapeutics
RPTX
$376K ﹤0.01%
+12,083
New +$396K
EZPW icon
2003
Ezcorp Inc
EZPW
$1.84B
$374K ﹤0.01%
+62,113
New +$392K
NBHC icon
2004
National Bank Holdings
NBHC
$1.91B
$374K ﹤0.01%
9,930
-4,059
-29% -$161K
CHPT.WS
2005
DELISTED
ChargePoint Holdings, Inc. Warrants, exercisable for one share of Common Stock
CHPT.WS
$374K ﹤0.01%
16,127
-300
-2% -$4.5K
FTEC icon
2006
Fidelity MSCI Information Technology Index ETF
FTEC
$21B
$373K ﹤0.01%
3,167
-8,836
-74% -$985K
SMPL icon
2007
Simply Good Foods
SMPL
$961M
$372K ﹤0.01%
+10,205
New +$349K
PINE
2008
Alpine Income Property Trust
PINE
$349M
$370K ﹤0.01%
+19,500
New +$357K
NWN icon
2009
Northwest Natural Holdings
NWN
$2.12B
$369K ﹤0.01%
7,039
-110,349
-94% -$5.97M
OTRK
2010
DELISTED
Ontrak
OTRK
$368K ﹤0.01%
+126
New +$364K
XERS icon
2011
Xeris Biopharma Holdings
XERS
$1.24B
$368K ﹤0.01%
+90,515
New +$345K
SBBP
2012
DELISTED
Strongbridge Biopharma plc.
SBBP
$368K ﹤0.01%
+124,115
New +$328K
ITOS
2013
DELISTED
iTeos Therapeutics
ITOS
$367K ﹤0.01%
+14,315
New +$341K
ZSL icon
2014
ProShares UltraShort Silver
ZSL
$56.2M
$367K ﹤0.01%
394
+144
+58% +$133K
IGNYU
2015
DELISTED
Ignyte Acquisition Corp. Unit
IGNYU
$367K ﹤0.01%
36,682
ABTS icon
2016
Abits Group
ABTS
$4.38M
$366K ﹤0.01%
1,096
-137
-11% -$21.7K
CVCO icon
2017
Cavco Industries
CVCO
$4.49B
$366K ﹤0.01%
1,648
+521
+46% +$114K
DGICA icon
2018
Donegal Group Class A
DGICA
$715M
$366K ﹤0.01%
25,130
-1,721
-6% -$26.3K
YARW
2019
Yarrow Bioscience, Inc. Common Stock
YARW
$110M
$366K ﹤0.01%
+116
New +$459K
PBFX
2020
DELISTED
PBF LOGISTICS LP
PBFX
$366K ﹤0.01%
+24,614
New +$374K
CHPM
2021
DELISTED
CHP Merger Corp. Class A Common Stock
CHPM
$366K ﹤0.01%
36,874
+1,200
+3% +$12K
GLD icon
2022
PUT
SPDR Gold Trust
GLD
$137B
$364K ﹤0.01%
2,200
-34,800
-94% -$5.91M
SU icon
2023
Suncor Energy
SU
$72B
$364K ﹤0.01%
+15,186
New +$348K
TCX icon
2024
Tucows
TCX
$156M
$364K ﹤0.01%
+4,540
New +$360K
CNCE
2025
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$363K ﹤0.01%
+86,083
New +$364K

Similar funds

HRT Financial's Q2 2021 Portfolio in Review

As of Q2 2021, HRT Financial held 3,895 positions worth $10.9B, up 10% from $9.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HRT Financial deployed $744M of net new capital in Q2 2021, opening 1,275 new positions and adding to 565 existing holdings. Its largest new stake was Linde: 872,603 shares worth $252M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $330M trimmed.

  • HRT Financial's largest Q2 2021 buy was Linde: 872,603 shares worth $252M.
  • HRT Financial added most to Invesco QQQ Trust in Q2 2021, an estimated $289M increase.
  • HRT Financial's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $330M.
  • HRT Financial fully exited Palantir in Q2 2021, selling an estimated $130M.
  • HRT Financial's ten largest holdings make up 31% of its $10.9B portfolio in Q2 2021.
  • HRT Financial opened 1,275 new positions and closed 1,134 in Q2 2021.
  • HRT Financial's portfolio value rose 10% quarter-over-quarter to $10.9B.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.